Detalhe da pesquisa
1.
Modulation of Biliary Cancer Chemo-Resistance Through MicroRNA-Mediated Rewiring of the Expansion of CD133+ Cells.
Hepatology
; 72(3): 982-996, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31879968
2.
Two first-in-human studies of xentuzumab, a humanised insulin-like growth factor (IGF)-neutralising antibody, in patients with advanced solid tumours.
Br J Cancer
; 122(9): 1324-1332, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32161368
3.
Safety, efficacy and survival of patients with primary malignant brain tumours (PMBT) in phase I (Ph1) trials: the 12-year Royal Marsden experience.
J Neurooncol
; 139(1): 107-116, 2018 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-29637509
4.
Outcomes of Patients Treated With RCHOP With a PET-Adapted Approach for Consolidative Radiotherapy: A Retrospective Single-Center Study at the Royal Marsden Hospital.
Clin Lymphoma Myeloma Leuk
; 24(1): 48-54, 2024 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37734988
5.
Previous immune checkpoint inhibitor therapy is associated with decreased COVID-19-related hospitalizations and complications in patients with cancer: Results of a propensity-matched analysis of the OnCovid registry.
Int J Infect Dis
; 139: 13-20, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38029831
6.
A Phase I Trial of CT900, a Novel α-Folate Receptor-Mediated Thymidylate Synthase Inhibitor, in Patients with Solid Tumors with Expansion Cohorts in Patients with High-Grade Serous Ovarian Cancer.
Clin Cancer Res
; 28(21): 4634-4641, 2022 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35984704
7.
The Impact of COVID-19 on the Delivery of Systemic Anti-Cancer Treatment at Guy's Cancer Centre.
Cancers (Basel)
; 14(2)2022 Jan 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35053432
8.
Modulation of pancreatic cancer cell sensitivity to FOLFIRINOX through microRNA-mediated regulation of DNA damage.
Nat Commun
; 12(1): 6738, 2021 11 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-34795259
9.
Phase I Trial of the PARP Inhibitor Olaparib and AKT Inhibitor Capivasertib in Patients with BRCA1/2- and Non-BRCA1/2-Mutant Cancers.
Cancer Discov
; 10(10): 1528-1543, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32532747
10.
Pseudoprogression on treatment with immune-checkpoint inhibitors in patients with gastrointestinal malignancies: Case series and short literature review.
Curr Probl Cancer
; 43(5): 487-494, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30827742
11.
The A.L.A.N. score identifies prognostic classes in advanced biliary cancer patients receiving first-line chemotherapy.
Eur J Cancer
; 117: 84-90, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31276980
12.
Clinical factors of response in patients with advanced ovarian cancer participating in early phase clinical trials.
Eur J Cancer
; 76: 52-59, 2017 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28273485
13.
Clinical outcomes and prognostic factors of patients with advanced mesothelioma treated in a phase I clinical trials unit.
Eur J Cancer
; 75: 56-62, 2017 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28214659
14.
EGFR-mutated lung cancer in Li-Fraumeni syndrome.
Lung Cancer
; 85(3): 485-7, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-25047674
15.
Neoadjuvant DCF vs. ACF for resectable oesophageal squamous cell carcinoma.
J Thorac Dis
; 9(9): 2868-2870, 2017 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-29221258
16.
Change in platelet levels during radiotherapy with concurrent and adjuvant temozolomide for the treatment of glioblastoma: a novel prognostic factor for survival.
J Cancer Res Clin Oncol
; 138(10): 1683-8, 2012 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-22644996